The Penang General Hospital is the main public hospital in the city of George Town in Penang, Malaysia. The largest public hospital in Penang, it also serves as the reference hospital within northern Malaysia. The hospital had its origins as a medical centre founded in 1854 for the poor and opium addicts.

There are 1,090 beds in Hospital Pulau Pinang.

During the past decade, Hospital Pulau Pinang conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 22 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 14 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Pulau Pinang" #1 sponsor was "Janssen Research & Development, LLC" with 14 trials, followed by "Boehringer Ingelheim" with 11 trials sponsored, "Baxalta now part of Shire" with 5 trials sponsored, "Ministry of Health, Malaysia" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Pulau Pinang" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator and "Actoverco" with 1 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Pulau Pinang" are "Hemophilia A" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Arthritis, Psoriatic" (3 trials), "Crohn's Disease" (3 trials) and "Generalized Pustular Psoriasis" (3 trials). Many other conditions were trialed in "Hospital Pulau Pinang" in a lesser frequency.

Most popular intervention types in "Hospital Pulau Pinang" are "Drug" (60 trials), "Biological" (10 trials), "Other" (7 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Carboplatin" (5 trials), "Filgotinib" (4 trials), "Guselkumab" (4 trials) and "PEGylated Recombinant Factor VIII" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Pulau Pinang" are 77 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Pulau Pinang". undefined are not yet recruiting, 15 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Hospital Pulau Pinang, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Pulau Pinang, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 7 trials that are defined as “Not Applicable".